P.J. Meier
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 16
- Drug Transport and Resistance Mechanisms 16
-
- Amino Acid Enzymes and Metabolism 4
- Co-authors
- Bruno HagenbuchBruno StiegerGerd A. Kullak‐UblickGerd FolkersXavier BossuytMichael MüllerJonas ValantinasG M Groothuis
- Journals
- Journal of Pharmacology and Experimental Therapeutics (3 papers)Journal of Hepatology (3 papers)Journal of Clinical Investigation (2 papers)Clinics in Liver Disease (1 paper)Current Drug Metabolism (1 paper)
- Partner nations
- SwitzerlandNetherlandsGermany
In The Last Decade
P.J. Meier
20 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Oncology 1.0k
- Pediatrics, Perinatology and Child Health 479
- Pharmacology 185
- Clinical Biochemistry 142
- Biochemistry 144
Countries citing papers authored by P.J. Meier
This map shows the geographic impact of P.J. Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.J. Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.J. Meier more than expected).
Fields of papers citing papers by P.J. Meier
This network shows the impact of papers produced by P.J. Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.J. Meier. The network helps show where P.J. Meier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P.J. Meier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 169 | |
| 2 | 2003 | 34 | |
| 3 | 2002 | 248 | |
| 4 | 2001 | 102 | |
| 5 | 2000 | 98 | |
| 6 | 2000 | 41 | |
| 7 | 2000 | 1 | |
| 8 | 1999 | 26 | |
| 9 | 1998 | 16 | |
| 10 | 1998 | 1 | |
| 11 | 1997 | 1 | |
| 12 | 1996 | 16 | |
| 13 | 1996 | 135 | |
| 14 | 1994 | 374 | |
| 15 | 1991 | 49 | |
| 16 | 1991 | 1 | |
| 17 | 1989 | 90 | |
| 18 | [Benzodiazepine--practice and problems of its use]. | 1988 | 7 |
| 19 | Deoxyribonucleic acid assessments on Feulgen-stained endometrial cells and comparison with fluorometric values on acridine-orange stained material. | 1965 | 4 |
| 20 | 1958 | 14 |
About P.J. Meier
P.J. Meier is a scholar working on Oncology, Biochemistry, Clinical Biochemistry, Pharmaceutical Science and Nutrition and Dietetics, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (16 papers), Amino Acid Enzymes and Metabolism (4 papers), Trace Elements in Health (3 papers), Metabolism and Genetic Disorders (3 papers), Pancreatic function and diabetes (3 papers), Neonatal Health and Biochemistry (2 papers), Drug Solubulity and Delivery Systems (2 papers) and Machine Learning in Bioinformatics (1 paper). The work is most often cited by research in Oncology (1.0k citations), Pediatrics, Perinatology and Child Health (479 citations), Pharmacology (185 citations), Clinical Biochemistry (142 citations) and Biochemistry (144 citations). P.J. Meier has collaborated with scholars based in Switzerland, Netherlands and Germany. Frequent co-authors include Bruno Hagenbuch, Bruno Stieger, Gerd A. Kullak‐Ublick, Gerd Folkers, Xavier Bossuyt, Michael Müller, Jonas Valantinas, G M Groothuis, Dirk Meijer and Hermann Koepsell. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Hepatology, Journal of Clinical Investigation, Clinics in Liver Disease and Current Drug Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.